Analyzing the Possible Impact of Herpes Simplex Virus-1 in Relation to Interleukin-6 Levels in Patients with Oral Squamous Cell Carcinoma

Background: Oral squamous cell carcinoma (OSCC) is the most common malignant tumor of the oral cavity, accounting for more than 90% of all cases. Oral herpes is caused by herpes simplex virus type 1 (HSV-1), a common, benign virus that affects the skin and mucous membranes of individuals with weakened immune systems, causing ulcers. There are several cellular processes that rely on the pleiotropic cytokine interleukin-6 (IL-6), including migration, invasion, differentiation, proliferation, and survival. By modifying tumor angiogenesis and tumor lymphangiogenesis, IL-6 controls tumor growth and its effects on tumor cells.Methods: The study involved 60 patients divided into two groups: those with and those without oral cancer. The blood was drawn and examined for HSV-1 Immunoglobulin G levels using the Herpe Select-1 ELISA kit. A sandwich ELISA was also employed to study IL-6 levels.Results: HSV-1 incidence in these oral squamous cell carcinoma grade groups increased significantly. This research found that the OSCC group had somewhat greater IL-6 levels than the control groups.Conclusion: HSV-1 is not carcinogenic in its own right; however, it is linked to an increased risk of oral squamous cell carcinoma. In addition, the present study discovered that the pro-inflammatory cytokine IL-6 was present in greater quantities in patients' blood than in controls. Interleukin-6 was identified as a potentially hazardous factor in the development of oral cancer and has the potential to function as a valuable biomarker for the assessment of OSCC severity.